Truist analyst Richard Newitter raised the firm’s price target on Inari Medical (NARI) to $63 from $50 and keeps a Hold rating on the shares as part of a broader research note previewing 2025 in ...

The analysts might have been a bit too bullish on Inari Amertron Berhad (KLSE:INARI), given that the company fell short of expectations when it released its full-year results last week. Inari Amertron ...

Inari Medical, Inc. is well-poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company’s dependency on the ...

Inari Medical Inc (NASDAQ:NARI) shares gained on Thursday after the company reported Q2 revenues of $119.0 million, up 28.3% Y/Y, beating the consensus of $116.28 million. The increase over the prior ...

Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news like ...

Funding will help Inari enhance its “toolbox” of seed technologies to reduce the world’s agricultural footprint and increase crop and food production for people around the world. “There are several ...

Further detail will be provided when Inari reports its financial results for the fourth quarter and full year 2023. The preliminary unaudited revenue results described in this press release are ...

Inari Amertron Bhd has terminated its proposed joint acquisition of Lumileds Holding BV after failing to secure regulatory approval from US authorities on national security concerns.